Beyond The Roundup | The NIH Updates Stance On Ivermectin

The National Institutes of Health (NIH) invited the Front Line COVID-19 Critical Care Alliance (FLCCC) to present to this national research agency’s COVID-19 Treatment Guidelines Panel. The Panel, which is the most influential of any such group worldwide, now is taking the time to review the unfolding Ivermectin situation. Of course, such a meeting wouldn’t be possible if it were not for the dedicated, committed and relentless efforts of the physician/researchers’ embrace of a story that we have been chronicling since April. The FLCCC, led by Dr. Pierre Kory and Dr. Paul Marik, along with prominent British researcher, Dr. Andrew Hill, affiliated with the University of Liverpool in the UK, presented their respective meta-analysis findings to date.

TrialSite News Related News Articles:

https://trialsitenews.com/nih-updates-its-covid-19-guidelines-for-ivermectin-while-flccc-pays-a-visit-to-hugh-hewitt/
https://trialsitenews.com/nih-covid-19-treatment-guidelines-panel-invites-top-ivermectin-researchers-to-discuss-the-evidence-of-efficacy-to-date/

Reference Links:

https://www.youtube.com/c/WhiteboardDoctor/
Dr. Kory radio interview:

https://hughhewitt.com/dr-pierre-kory-of-the-flccc-alliance-on-the-therapeutic-value-of-ivermectin-in-treatment-of-covid/